Retraction notice to: "LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis" Biomed. Pharmacother. 125 (2020) 110039.
作者信息
Wen Dacheng, Li Songhe, Jiang Weidong, Zhao Shutao, Liu Jingjing, Zhu Jiaming
机构信息
Department of Gastrointestinal Nutrition and Hernia Surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
Department of Ophthalmology, the First Hospital of Jilin University, Chaoyang District, Changchun 130021, China.
出版信息
Biomed Pharmacother. 2023 Oct;166:114877. doi: 10.1016/j.biopha.2023.114877. Epub 2023 Jun 21.
PMID:37353385
Abstract
摘要
相似文献
1
Retraction notice to: "LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis" Biomed. Pharmacother. 125 (2020) 110039.撤回通知：“LncRNA SNHG3通过调控miR-539/RUNX2轴促进结直肠癌的生长和转移”，《生物医学与药物治疗》，125卷（2020年），第110039页 。
Biomed Pharmacother. 2023 Oct;166:114877. doi: 10.1016/j.biopha.2023.114877. Epub 2023 Jun 21.
2
Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
Biomed Pharmacother. 2022 Jun;150:112855. doi: 10.1016/j.biopha.2022.112855. Epub 2022 Mar 25.
3
Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
Biomed Pharmacother. 2023 Nov;167:115375. doi: 10.1016/j.biopha.2023.115375. Epub 2023 Oct 5.
4
Retraction notice to "LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p" [Biomed. Pharmacother. 114 (2019) 108862].对“LncRNA SNHG16通过靶向miR-218-5p促进胰腺癌肿瘤生长”[《生物医学与药物治疗》114 (2019) 108862]的撤稿通知。
Biomed Pharmacother. 2024 Feb;171:116188. doi: 10.1016/j.biopha.2024.116188. Epub 2024 Jan 30.
5
Retraction notice to "Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN" [Biomed. Pharmacother. 109 (2019) 2035-2042].
Biomed Pharmacother. 2023 Nov;167:115370. doi: 10.1016/j.biopha.2023.115370. Epub 2023 Oct 5.
6
Retraction notice to "lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer" [Biomed. Pharmacother. 114 (2019) 108814].
Biomed Pharmacother. 2022 Jan;145:112511. doi: 10.1016/j.biopha.2021.112511. Epub 2021 Dec 9.
7
Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].
Biomed Pharmacother. 2023 Dec 31;169:115376. doi: 10.1016/j.biopha.2023.115376. Epub 2023 Nov 27.
8
Retraction notice to "Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis" [Biomed. Pharmacother. 107(2018) 547-554].对“敲低lncRNA XIST通过调节miR-124/STAT3轴抑制视网膜母细胞瘤进展”[《生物医学与药物治疗》107(2018) 547 - 554]的撤稿通知
Biomed Pharmacother. 2022 May;149:112795. doi: 10.1016/j.biopha.2022.112795. Epub 2022 Mar 11.
9
Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
Biomed Pharmacother. 2024 Mar;172:116198. doi: 10.1016/j.biopha.2024.116198. Epub 2024 Jan 30.
10
Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
Biomed Pharmacother. 2023 Aug;164:114728. doi: 10.1016/j.biopha.2023.114728. Epub 2023 Apr 20.
Zotero 插件